Usana Health Sciences's three largest insider shareholders as of June 02, 2026 are Myron W Wentz (TenPercentOwner, 7.41Mn shares), Kevin Guest (Ceo Exec. Chairman Of Board, 45.38K shares), Jim Brown (Ceo President, 16.93K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Myron W Wentz | - | 0 | 7,408,345 | 05 Sep, 2025 |
| Robert Auciaux | - | 8,092 | 0 | 11 May, 2022 |
| G Doug Iiekking | Chief Financial Officer | 5,360 | 0 | 02 Mar, 2026 |
| Timothy E Wood | E.V.P. Of R And D | 9,820 | 0 | 26 Jan, 2026 |
| Robert A Sinnott | Chief Scientific Officer | 318 | 0 | 26 Oct, 2021 |
| Kevin Guest | Ceo Exec. Chairman Of Board | 45,381 | 0 | 03 Mar, 2026 |
| Jim Brown | Ceo President | 16,934 | 0 | 28 Jul, 2025 |
| Paul A. Jones | Chief People Officer | 12,374 | 0 | 03 Mar, 2026 |
| Frederic J Winssinger | - | 7,044 | 0 | 26 Jan, 2026 |
| Walter Noot | Chief Operating Officer | 9,256 | 0 | 03 Mar, 2026 |
| David Mulham Mulham | Chief Sales Officer | 8,387 | 0 | 11 Dec, 2025 |
| J Scott Nixon | - | 8,756 | 0 | 26 Jan, 2026 |
| Joshua Foukas | Chief Legal Officer | 3,791 | 0 | 03 Mar, 2026 |
| Peggie Pelosi | - | 4,975 | 0 | 26 Jan, 2026 |
| Brent Neidig | Chief Commercial Officer | 7,513 | 0 | 03 Mar, 2026 |
| John Turman Fleming | - | 5,623 | 0 | 26 Jan, 2026 |
| Xia Ding | - | 6,584 | 0 | 26 Jan, 2026 |
| Kathryn Michelle Armstrong | Chief Scientific Officer | 2,823 | 0 | 03 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | Gilbert A Fuller | Common Stock | D | 1,058 | $17.00 | 0 | D | S |
| 03 Mar, 2026 | Peter Benedict | Common Stock | D | 4,553 | $19.38 | 0 | D | S |
| 27 Feb, 2026 | Brent Neidig | Common Stock | A | 6,747 | - | 10,506 | D | M |
| 27 Feb, 2026 | Peter Benedict | Common Stock | A | 3,906 | - | 5,727 | D | M |
| 27 Feb, 2026 | Paul A. Jones | Common Stock | A | 4,596 | - | 13,723 | D | M |
| 27 Feb, 2026 | Walter Noot | Common Stock | A | 7,422 | - | 12,400 | D | M |
| 27 Feb, 2026 | Kevin Guest | Common Stock | A | 7,856 | - | 48,709 | D | M |
| 27 Feb, 2026 | Kathryn Michelle Armstrong | Common Stock | A | 4,190 | - | 4,838 | D | M |
| 27 Feb, 2026 | Joshua Foukas | Common Stock | A | 6,577 | - | 6,577 | D | M |
| 27 Feb, 2026 | Peter Benedict | Common Stock | D | 1,174 | $21.52 | 4,553 | D | F |
| 27 Feb, 2026 | Paul A. Jones | Common Stock | D | 1,349 | $21.52 | 12,374 | D | F |
| 27 Feb, 2026 | Walter Noot | Common Stock | D | 3,144 | $21.52 | 9,256 | D | F |
| 27 Feb, 2026 | Kevin Guest | Common Stock | D | 3,328 | $21.52 | 45,381 | D | F |
| 27 Feb, 2026 | Joshua Foukas | Common Stock | D | 2,786 | $21.52 | 3,791 | D | F |
| 27 Feb, 2026 | Kathryn Michelle Armstrong | Common Stock | D | 2,015 | $21.52 | 2,823 | D | F |
| 27 Feb, 2026 | Brent Neidig | Common Stock | D | 2,993 | $21.52 | 7,513 | D | F |
| 27 Feb, 2026 | Walter Noot | Restricted Stock Units | D | 7,422 | $0.00 | 75,130 | D | M |
| 27 Feb, 2026 | Brent Neidig | Restricted Stock Units | D | 6,747 | $0.00 | 67,447 | D | M |
| 27 Feb, 2026 | Peter Benedict | Restricted Stock Units | D | 3,906 | $0.00 | 38,602 | D | M |
| 27 Feb, 2026 | Kevin Guest | Restricted Stock Units | D | 7,856 | $0.00 | 127,206 | D | M |